The path to successful commercialization of cell and gene therapies: empowering patient advocates-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The path to successful commercialization of cell and gene therapies: empowering patient advocates

Published:2017-02 Issue:2 Volume:19 Page:293-298
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Bauer Gerhard,Abou-El-Enein Mohamed,Kent Alastair,Poole Brian,Forte Miguel

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference25 articles.

1. Gene therapy returns to centre stage;Naldini;Nature,2015

2. Cell and gene therapies and the evolving role of personalized medicine;Marshall;Cell Gene Ther Insights,2016

3. Positioning a scientific community on unproven cellular therapies: the 2015 International Society for Cellular Therapy Perspective;Dominici;Cytotherapy,2015

4. Commercialization and stem cell research: a review of emerging issues;Burningham;Stem Cells Dev,2013

5. Gene therapy: a possible future standard for HIV care;Abou-El-Enein;Trends Biotechnol,2015

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials;IBRO Neuroscience Reports;2023-06

2. Unproven Stem Cell-Based Interventions: Addressing Patients’ Unmet Needs or Causing Patient Harms?;Philosophy and Medicine;2023

3. Central Nervous System Gene Therapy: Present Developments and Emerging Trends Accelerating Industry-Academia Pathways;Human Gene Therapy;2022-09-01

4. Understanding potential barriers and enablers to a perioperative early phase cell therapy trial;Cytotherapy;2022-06

5. Policies and Governance of Knowledge Commercialization in IRAN;Global Encyclopedia of Public Administration, Public Policy, and Governance;2022

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3